Thieler Law Corp advises investors with losses exceeding $100,000 of the October 4, 2019 lead plaintiff deadline in a class action lawsuit filed against Curaleaf Holdings Inc (OTC: CURLF) (“Curaleaf” or “the Company”). The suit is pending in the U.S. District Court for the Eastern District of New York and investors, who purchased Curaleaf Holdings Inc securities between November 21, 2018 and July 22, 2019, have until October 4, 2019 to move for lead plaintiff. You do not need to move for lead plaintiff to be a member of the Class.

If you purchased Curaleaf Holdings Inc securities during the Class Period, and have losses over $100,000, you may contact Thieler Law Corp by calling at (619) 377 - 4324 or emailing mail@thielerlaw.com . No class has been certified in this case, and if your losses are less than $100,000 you are still a member of the class.

The complaint alleges that during the Class Period defendants made false and misleading statements and/or allegedly failed to disclose that Curaleaf, on its website and social media pages, marketed its CBD products to be used as drugs and dietary supplements, contrary to law; Curaleaf also sold unapproved animal drugs on its website; such conduct would result in a warning letter from the U.S. Food and Drug Administration (“FDA”); and as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

On July 22, 2019, the FDA sent a warning letter to Curaleaf regarding several CBD products sold on its website. The Warning Letter noted that Curaleaf was selling unapproved new and misbranded drugs, improperly marketing its CBD products as dietary supplements, and selling unapproved new animal drugs in violation of the Federal Food, Drug, and Cosmetic Act.

Following this news, OTC: CURLF fell $0.58 per share, or 7.27%, to close at $7.40 per share on July 23, 2019.

If you were negatively impacted by your investment in Curaleaf Holdings Inc securities between November 21, 2018 and July 22, 2019 and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation.

Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm. Materials are provided for informational purposes only and do not constitute legal advice. We are only licensed to practice law in Germany. We are neither licensed nor qualified to render advice on US Federal or State law.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/

or

Facsimile: +1 (619) 785 – 3185